Bishoy Faltas, MD


6223 IH10 WEST


Opportunistic Infections Unmasked After Initiation of cART: What Is the Risk?

November 20, 2014

Immune reconstitution inflammatory syndrome is seen in some HIV-infected patients soon after initiation of antiretroviral therapy. The syndrome can “unmask” dormant opportunistic infections or aggravate existing infections.

Nevirapine-based HAART Regimens: What Effect on HIV-Associated Lipodystrophy?

November 20, 2014

Long-term highly-active antiretroviral therapy can be associated with disturbing morphologic and metabolic changes. Nevaripine is added to three HAART regimens in this study to evaluate any mitigating effects.

HIV-Infected But Non-Progressing: What Is the Risk for AIDS?

October 20, 2014

For patients who remained AIDS-free and untreated 10 years after seroconversion, loss of this status was associated with lower CD4 cell counts and higher HIV RNA load.

What Cause of Low Bone Mineral Density in HIV-Positive Patients?

October 20, 2014

Results of a recent study found low BMD was strongly associated with body weight, smoking, and prior advanced HIV disease.

Statin Use Affects Cancer Risk in HIV-Infected Patients

October 20, 2014

A retrospective chart review among HIV-infected patients treated with ART found use of statin medications associated with a lower risk of cancer.

Dyslipidemia and Hypertension Control in HIV-Positive Patients

September 18, 2014

HIV-infected patients have a 2-fold increased risk for MI vs HIV-negative patients. While many are treated for common risk factors, many of those do not reach clinical targets.